These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26290264)

  • 1. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.
    McIntyre RS; Xiao HX; Syeda K; Vinberg M; Carvalho AF; Mansur RB; Maruschak N; Cha DS
    CNS Drugs; 2015 Jul; 29(7):577-89. PubMed ID: 26290264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder.
    Pan Z; Grovu RC; Cha DS; Carmona NE; Subramaniapillai M; Shekotikhina M; Rong C; Lee Y; McIntyre RS
    CNS Neurol Disord Drug Targets; 2017; 16(8):891-899. PubMed ID: 28933261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI).
    McIntyre RS; Lee Y
    Curr Opin Psychiatry; 2016 Jan; 29(1):48-55. PubMed ID: 26575300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognition as a target in major depression: new developments.
    Solé B; Jiménez E; Martinez-Aran A; Vieta E
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):231-47. PubMed ID: 25640673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in major depressive disorder.
    Pan Z; Park C; Brietzke E; Zuckerman H; Rong C; Mansur RB; Fus D; Subramaniapillai M; Lee Y; McIntyre RS
    CNS Spectr; 2019 Feb; 24(1):22-29. PubMed ID: 30468135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review.
    Bortolato B; Carvalho AF; McIntyre RS
    CNS Neurol Disord Drug Targets; 2014; 13(10):1804-18. PubMed ID: 25470396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review.
    Blumberg MJ; Vaccarino SR; McInerney SJ
    J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32726521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives.
    Salagre E; Solé B; Tomioka Y; Fernandes BS; Hidalgo-Mazzei D; Garriga M; Jimenez E; Sanchez-Moreno J; Vieta E; Grande I
    J Affect Disord; 2017 Oct; 221():205-221. PubMed ID: 28651185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating to target in major depressive disorder: response to remission to functional recovery.
    McIntyre RS; Lee Y; Mansur RB
    CNS Spectr; 2015 Dec; 20 Suppl 1():20-30; quiz 31. PubMed ID: 26683526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions.
    McIntyre RS; Cha DS; Soczynska JK; Woldeyohannes HO; Gallaugher LA; Kudlow P; Alsuwaidan M; Baskaran A
    Depress Anxiety; 2013 Jun; 30(6):515-27. PubMed ID: 23468126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder.
    McIntyre RS; Suppes T; Tandon R; Ostacher M
    J Clin Psychiatry; 2017 Jun; 78(6):703-713. PubMed ID: 28682531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice.
    Papakostas GI
    J Clin Psychiatry; 2014 Jan; 75(1):8-14. PubMed ID: 24345473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field.
    Miskowiak KW; Ott CV; Petersen JZ; Kessing LV
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1845-1867. PubMed ID: 27745932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder.
    Bakkour N; Samp J; Akhras K; El Hammi E; Soussi I; Zahra F; Duru G; Kooli A; Toumi M
    Psychiatry Res; 2014 May; 216(3):291-302. PubMed ID: 24656516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using measurement strategies to identify and monitor residual symptoms.
    McIntyre RS
    J Clin Psychiatry; 2013; 74 Suppl 2():14-8. PubMed ID: 24191973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential effect of herbal antidepressants on cognitive deficit: Pharmacological activity and possible molecular mechanism.
    Li JM; Zhao Y; Sun Y; Kong LD
    J Ethnopharmacol; 2020 Jul; 257():112830. PubMed ID: 32259666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive dysfunction in depression - pathophysiology and novel targets.
    Carvalho AF; Miskowiak KK; Hyphantis TN; Kohler CA; Alves GS; Bortolato B; G Sales PM; Machado-Vieira R; Berk M; McIntyre RS
    CNS Neurol Disord Drug Targets; 2014; 13(10):1819-35. PubMed ID: 25470397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction in unipolar depression: implications for treatment.
    Trivedi MH; Greer TL
    J Affect Disord; 2014 Jan; 152-154():19-27. PubMed ID: 24215896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive remission: a novel objective for the treatment of major depression?
    Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
    BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.